Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Nephropathy Type 2”

309 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 309 results

Post-approval studies (Phase 4)Looking for participantsNCT05390892
What this trial is testing

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Who this might be right for
Type2DiabetesASCVD
Brigham and Women's Hospital 6,000
Not applicableActive Not RecruitingNCT04960514
What this trial is testing

Prospective Decision Impact Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2+1 more
Renalytix AI, Inc. 2,000
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Post-approval studies (Phase 4)Study completedNCT03006952
What this trial is testing

Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

Who this might be right for
Diabetic Nephropathies
Tehran University of Medical Sciences 59
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Post-approval studies (Phase 4)Study completedNCT00363987
What this trial is testing

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Who this might be right for
Diabetic Nephropathy
Fresenius Kabi 179
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Testing effectiveness (Phase 2)Study completedNCT00811889
What this trial is testing

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesDiabetic Nephropathy
Biogen 227
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Large-scale testing (Phase 3)Study completedNCT04881123
What this trial is testing

SER150 vs Placebo in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Serodus AS 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Testing effectiveness (Phase 2)Study completedNCT02836574
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 83
Not applicableStudy completedNCT03889236
What this trial is testing

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.

Who this might be right for
Diabetic Nephropathy Type 2AlbuminuriaType2 Diabetes Mellitus+7 more
Leiden University Medical Center 56
Not applicableNot Yet RecruitingNCT07833228
What this trial is testing

Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)Diabetic NephropathiesDiabetic Retinopathy (DR)
Shanghai Jiao Tong University School of Medicine 1,200
Testing effectiveness (Phase 2)Study completedNCT01399580
What this trial is testing

A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06866158
What this trial is testing

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease (DKD)
PT. JES Kasih Nusantara Sejahterah 80
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Next Page